Medicine and Dentistry
Transplantation
100%
Multiple Myeloma
100%
Patient
81%
Primary Tumor
37%
Lenalidomide
31%
Diagnosis
12%
Autologous Stem Cell Transplantation
12%
Incidence
6%
Age
6%
Therapeutic Procedure
6%
Multivariate Analysis
6%
Survival
6%
Death
6%
Follow up
6%
Cyclophosphamide
6%
Drug Megadose
6%
Doxorubicin
6%
Hematologic Malignancy
6%
Life Expectancy
6%
Peripheral Blood Stem Cell
6%
Thalidomide
6%
Hematological Cancer
6%
Immunology and Microbiology
Transplantation
100%
Multiple Myeloma
100%
Lenalidomide
31%
Autologous Stem Cell Transplantation
12%
Age
6%
Incidence
6%
Time
6%
Survival
6%
Cyclophosphamide
6%
Drug Megadose
6%
Peripheral Blood Stem Cell
6%
Thalidomide
6%
Life Expectancy
6%
Biochemistry, Genetics and Molecular Biology
Autologous Stem Cell Transplantation
12%
Time
6%
Age
6%
Incidence
6%
Multivariate Analysis
6%
Survival
6%
Cyclophosphamide
6%
Drug Megadose
6%
Life Expectancy
6%
Neuroscience
Lenalidomide
31%
Cyclophosphamide
6%
Thalidomide
6%